Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
National Institutes of Health (NIH)
Funding amount is not limited but must reflect the actual needs of the proposed project.
Maximum project period is 5 years.
To support innovative studies investigating biological/genetic contributors to cancer health disparities.
To facilitate the growth of a nationwide cohort of scientists with expertise in cancer health disparities research.
Investigators conducting basic cancer research.
Racial and ethnic populations affected by cancer health disparities.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local, state, and federal governments.
Specific qualifications include having the skills, knowledge, and resources necessary to carry out the proposed research.
Organizations from the U.S. and foreign organizations are eligible to apply.
Non-domestic components of U.S. organizations are also eligible.
Projects must focus on basic cancer research related to health disparities.
Studies should investigate biological factors associated with cancer disparities.
No cost sharing is required.
Application budgets are not limited but must reflect actual project needs.
Application due date is January 7, 2028.
Applications must be submitted electronically.
Organizations may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or overlapping applications.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on significance, innovation, rigor, and feasibility.
Applications will undergo peer review and receive a written critique.
Scientific and technical merit of the proposed project will be considered.
Immediate clinically translational potential is not a requirement for the proposed projects.
Applications proposing studies that do not focus on cancer health disparities will be considered non-responsive.
Projects should align with NIH's mission to improve health outcomes for underserved populations.
Diverse applicant pool may lead to competitive applications focusing on innovative methodologies.
Strong emphasis on biological mechanisms contributing to cancer disparities.
Avoid submitting overlapping applications.
Ensure compliance with all application instructions to avoid delays.
Highlight unique aspects of proposed research to stand out in the review process.